Peerbridge Health & Northwell Health Launch Pilot Program to Optimize Treatment for AFib Patients at Lenox Hill Hospital

Peerbridge Health is collaborating with Northwell Health on their newly launched AFib Center of Excellence, a mutli-displinary effort that optimizes treatment for patients with atrial fibrillation (AFib). With Peerbridge’s support, Northwell’s AFib Center of Excellence will conduct a pilot program focusing on AFib patients with undiagnosed obstructive sleep apnea (OSA).

The pilot aims to help cardiology and sleep physicians better understand the critical link between the two conditions, and how best to quickly and effectively treat AFib and OSA concurrently.

“More than 50% of AFib patients referred for ablation also suffer from undiagnosed sleep apnea, and this remains an underdiagnosed risk factor” said Dr. Nicholas Skipitaris, Western Regional Director of Cardiac Electrophysiology, Northwell Health. “We must address both issues for the best health outcomes. Our pilot program with Peerbridge helps us accomplish this by giving us the best and most accurate data as quickly as possible, and ensuring each patient is properly treated through an individualized approach.”

If left untreated, sleep apnea increases the likelihood of poor health outcomes for this patient population by more than 50 percent, including failed treatments, heart failure, and sudden cardiac death. This contributes to more than $150 billion in healthcare waste each year.

During the pilot, patients will use the Peerbridge Cor™, a multi-channel wireless electrocardiogram (ECG) patch that records every heartbeat while transmitting patient activated events in near-real-time. The Cor is the only wireless ECG patch that can identify and quantify 31 rhythm statements, and accurately assess severity of AFib burden.

“A multi-specialty approach to early diagnosis and treatment of AFib will result in improved health outcomes for our patients,” said Dr. Varinder Singh, Chairman of Cardiovascular Medicine, Lenox Hill Hospital, Northwell Health. “This is especially important for high risk patients – like those with OSA or “master athletes” who compete in endurance events like the New York City Marathon – which we’re seeing more of in our clinical cardiovascular practice.”

Peerbridge is partnering with several sleep industry leaders to address the connection between AFib and OSA, including BetterNight. Peerbridge Health and BetterNight are partnering on a unique new care management solution designed specifically for cardiology practices for earlier identification, treatment, and optimization of ongoing care management of patients with atrial fibrillation (AFib) and obstructive sleep apnea (OSA). The partnership addresses a critical unmet need in the market where there is currently a lack of coordinated care for patients with both AFib and OSA. In addition, this collaboration aims to improve overall patient outcomes and has the potential to save healthcare providers thousands of dollars per patient each year by accelerating diagnosis and treatment of these prevalent conditions.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy